Treatment.com AI Inc. (TREIF)
| Previous close | 0.4174 |
| Open | 0.4185 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.3951 - 0.4185 |
| 52-week range | 0.0210 - 1.1940 |
| Volume | |
| Avg. volume | 14,255 |
| Market cap | 14.924M |
| Beta (5Y monthly) | -0.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1900 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireTreatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to announce the appointment of Richard Atkins as Chief Operating Officer and a member of the executive team. Mr. Atkins brings to the business a successful career with over 30 years’ experience in international sales, partnerships, executive manage
- GlobeNewswire
Treatment.com AI Announces Contract Renewal with Leading US Medical School
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“MES”). Treatment is also in discussions with a number of other medical and nursing schools, both in the US and internationally. As reported previously, the market in the US alone comprises 300 medical sc
- GlobeNewswire
Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“ MES ”) designed to educate the next generation of healthcare providers. Treatment’s MES enhances the entire continuum of clinical content education, from simple introductory patient interactions to more advanc
